High KP. Overcoming Barriers to Adult Immunization. J Am Osteopath Assoc 2009;109(6_suppl_2):S25–S28. doi: .
Download citation file:
The herpes zoster vaccine has proven to reduce the incidence of herpes zoster and postherpetic neuralgia, a debilitating condition that can remain for years after zoster rash has resolved. However, few eligible adults have received the vaccine. Findings from survey-based studies on patient uptake of influenza and pneumococcal polysaccharide vaccines suggest that physician recommendations and standing orders can increase vaccine uptake. However, certain barriers unique to zoster vaccination (eg, reimbursement concerns) will need to be addressed.
This PDF is available to Subscribers Only
View Article Abstract & Purchase Options